NCT03729804 2026-03-04
(COBRA)
University of Chicago
Phase 3 Active not recruiting
Clinical Trials
6 trialsNCT05675319 2026-01-05
AlloRelapseMM
Universitätsklinikum Hamburg-Eppendorf
Phase 3 Terminated
NCT04096066 2025-01-15
KRdvsRd
Fondazione EMN Italy Onlus
Phase 3 Active not recruiting
NCT03948035 2023-05-06
Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM
Wuerzburg University Hospital
Phase 3 Active not recruiting
NCT04288765 2021-07-09
Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma
Grupo Cooperativo de Hemopatías Malignas
Phase 3 Withdrawn
NCT01554852 2018-06-11
Myeloma XI
University of Leeds
Phase 3 Unknown